Primary sourcePérez-Castro S, D'Auria G, Llambrich M, Fernández-Barrés S, Lopez-Espinosa MJ, Llop S, Regueiro B, Bustamante M, Francino MP, Vrijheid M, Maitre L (2024). Influence of perinatal and childhood exposure to tobacco and mercury in children's gut microbiota. Frontiers in Microbiology, 14:1258988.
PubMed Central (Frontiers in Microbiology): https://pmc.ncbi.nlm.nih.gov/articles/PMC10799562/

What the study examined

Pérez-Castro and colleagues analyzed stool from 151 seven-year-old children in the INMA-Sabadell birth cohort (Spain), a prospective study that tracked environmental exposures from pregnancy onward. The team profiled the fecal microbiome by 16S rRNA amplicon sequencing (V3–V4 hypervariable regions) and tested whether two prenatal and childhood exposures — tobacco smoke and mercury — left a detectable mark on gut community composition years later.

Tobacco exposure was resolved by timing and persistence: active maternal smoking at any point in pregnancy, and sustained smoking across the first through third trimesters. Mercury exposure was assessed as a separate environmental toxicant. Because measurements were made at age 7, the design specifically probes whether an in-utero exposure produces a durable, rather than transient, microbiome effect.

The key findings

Active maternal smoking at any time during pregnancy was associated with a decreased relative abundance of Akkermansia (q = 0.005), a mucin-degrading genus tied to gut-barrier integrity and metabolic health. Sustained smoking from the first to the third trimester was associated with an increased relative abundance of Dorea (q = 0.01). Active prenatal smoking explained roughly 2–4% of overall between-sample β-diversity variability (Aitchison distance).

The effect was specific to prenatal timing and to tobacco. No comparable microbiome signal was detected for tobacco exposure during childhood, and mercury exposure showed no significant associations at the genus level. That contrast — prenatal but not later exposure, tobacco but not mercury — points to a developmental window in which the fetal and early-infant microbiome is uniquely sensitive to smoke-borne insults.

Why Akkermansia and Dorea matter

Akkermansia muciniphila is one of the most studied beneficial commensals: it grazes on the intestinal mucus layer, stimulates mucin turnover, and is repeatedly reported at reduced abundance in obesity, type 2 diabetes, and inflammatory conditions. A prenatally programmed depletion of Akkermansia is therefore a plausible early nudge toward metabolic and barrier dysfunction later in childhood.

Dorea, a short-chain-fatty-acid-associated Firmicutes genus, has been linked in several cohorts to overweight and altered energy harvest. An upward shift in Dorea alongside reduced Akkermansia is consistent with the broader literature connecting maternal smoking to elevated childhood overweight and obesity risk, some of which appears to be mediated through the gut microbiome.

How this fits the metal–microbiome–disease axis

Tobacco is a well-characterized non-occupational source of toxic metals. The tobacco plant bioaccumulates cadmium from soil, and combustion delivers both cadmium and lead into mainstream and sidestream smoke; maternal smoking raises cadmium and lead burdens that can cross the placenta and reach the fetus. Prenatal smoke thus doubles as a prenatal toxic-metal exposure, even though this study measured mercury rather than cadmium or lead directly.

The metal–microbiome–disease axis holds that heavy-metal exposure reshapes microbial communities, and that microbiome disruption in turn drives disease. The tobacco signal here fits that framework cleanly: a metal-bearing in-utero exposure produces a durable community shift (down Akkermansia, up Dorea) in a direction independently associated with metabolic disease. Experimental work supports the mechanistic link — dietary cadmium and lead alter gut community structure, thin the mucus layer, and perturb metal homeostasis and nutritional immunity in the gut.

An honest caveat anchors the interpretation: this cohort did not assay cadmium or lead, and its one directly measured metal, mercury, showed no genus-level association. The tobacco-to-metal link is therefore inferential, drawn from smoke chemistry rather than measured body burdens in these children. The finding is best read as consistent with, not proof of, a metal-driven mechanism — a signal that motivates cohorts pairing prenatal smoke with direct cadmium and lead biomonitoring.

Strength of the evidence

This is a modest-sized (n = 151), single-cohort, observational study, and the associations are correlational. Residual confounding by diet, socioeconomic status, delivery mode, and breastfeeding is difficult to fully exclude, and 16S profiling resolves genera rather than species or function. Its distinctive contribution is the long follow-up: detecting a prenatal smoke signature that persists to age 7 argues for durable early-life programming rather than a passing perturbation.

Complementary cohorts strengthen the overall picture. The Canadian CHILD study and other prospective series link maternal prenatal smoking to shifts in infant Firmicutes and to microbiome-mediated childhood overweight, and systematic reviews of perinatal smoke and the offspring microbiome converge on consistent, if heterogeneous, community effects. Together they make prenatal tobacco one of the better-supported early-life environmental modifiers of the child gut microbiome.

Key findings

  • Active maternal smoking at any point in pregnancy was associated with reduced gut Akkermansia (q = 0.005) in 7-year-olds in the INMA-Sabadell cohort (n = 151).
  • Sustained first-to-third-trimester smoking was associated with increased Dorea (q = 0.01); prenatal smoking explained roughly 2–4% of β-diversity variability.
  • The effect was specific to prenatal timing and to tobacco — childhood tobacco exposure and mercury showed no significant genus-level association.
  • Reduced Akkermansia and elevated Dorea align with microbiome patterns independently linked to childhood overweight and metabolic dysfunction.
  • Tobacco smoke is a major source of cadmium and lead, framing prenatal smoke as a plausible route for toxic-metal reshaping of the developing microbiome.
  • The metal link is inferential here: cadmium and lead were not measured, and the one measured metal (mercury) showed no association.

Frequently asked questions

Does prenatal tobacco exposure change a child's gut microbiome?

Yes. In the INMA-Sabadell birth cohort, children whose mothers smoked during pregnancy had lower Akkermansia and higher Dorea in their gut at age 7 — a durable signature not seen with childhood-only tobacco exposure, suggesting the fetal and infant period is a sensitive window.

How is tobacco smoke connected to heavy metals like cadmium and lead?

The tobacco plant accumulates cadmium from soil, and burning cigarettes releases both cadmium and lead into smoke. Maternal smoking raises cadmium and lead exposure that can cross the placenta, so prenatal tobacco smoke effectively delivers toxic metals to the developing fetus.

Why does lower Akkermansia matter for a child's health?

Akkermansia muciniphila maintains the intestinal mucus barrier and supports metabolic health; it is repeatedly found depleted in obesity and type 2 diabetes. A prenatally programmed drop in Akkermansia may nudge a child toward later metabolic and gut-barrier problems.

Did the study prove that cadmium or lead caused the microbiome changes?

No. The study measured tobacco smoke and mercury, not cadmium or lead, and mercury showed no effect. The cadmium and lead link is inferred from smoke chemistry and supporting experimental work, so the finding is consistent with — but not direct proof of — a metal-driven mechanism.